Synonyms: | |
Status: | Phase 3 |
Entry Type: | Antibody |
Molecule Category: | UKNOWN |
UNII: | 6XG22YQM2Z |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Esophageal Neoplasms | 3 | D004938 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 3 | D002289 | ClinicalTrials |
Esophageal Neoplasms | 3 | D004938 | ClinicalTrials |
Small Cell Lung Carcinoma | 3 | D055752 | ClinicalTrials |
Esophageal Neoplasms | 3 | D004938 | ClinicalTrials |
Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
Stomach Neoplasms | 1 | D013274 | ClinicalTrials |
Triple Negative Breast Neoplasms | 1 | D064726 | ClinicalTrials |
Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
Liver Neoplasms | 1 | D008113 | ClinicalTrials |
Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL4298050 |
FDA SRS | 6XG22YQM2Z |